MedPath

Albert Schweitzer Hospital

🇭🇹Haiti
Ownership
-
Established
1913-01-01
Employees
-
Market Cap
-
Website
http://www.schweitzerfellowship.org/features/lamb/hosp.aspx

Clinical Trials

22

Active:5
Completed:11

Trial Phases

5 Phases

Phase 1:5
Phase 2:3
Phase 3:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (26.3%)
Phase 1
5 (26.3%)
Phase 4
5 (26.3%)
Phase 2
3 (15.8%)
Phase 3
1 (5.3%)

Optimal Stent Deployment Strategy of Contemporary Stents

Not Applicable
Recruiting
Conditions
Coronary Artery Disease
First Posted Date
2022-03-23
Last Posted Date
2024-02-01
Lead Sponsor
Albert Schweitzer Hospital
Target Recruit Count
248
Registration Number
NCT05292651
Locations
🇳🇱

Albert Schweitzer hospital, Dordrecht, Netherlands

Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria

Not Applicable
Completed
Conditions
Malaria
Interventions
First Posted Date
2015-08-19
Last Posted Date
2017-01-25
Lead Sponsor
Albert Schweitzer Hospital
Target Recruit Count
50
Registration Number
NCT02528279
Locations
🇬🇦

Centre de Recherches Médicales de Lambaréné, Hôpital Albert Schweitzer, Lambaréné, Moyen-Ogooué, Gabon

🇬🇦

Centre de Recherches Médicales de Ngounié, Fougamou, Ngounié, Gabon

Upper Extremity Dysfunction Post Radial Percutaneous Coronary Intervention

Not Applicable
Conditions
Upper Extremity Dysfunction
First Posted Date
2014-07-30
Last Posted Date
2014-07-30
Lead Sponsor
Albert Schweitzer Hospital
Target Recruit Count
500
Registration Number
NCT02204423
Locations
🇳🇱

Albert Schweitzer Hospital, Dordrecht, Zuid-Holland, Netherlands

Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora

Phase 4
Completed
Conditions
Intestinal Diseases
Helminthiasis
Interventions
First Posted Date
2010-09-01
Last Posted Date
2013-01-24
Lead Sponsor
Albert Schweitzer Hospital
Target Recruit Count
200
Registration Number
NCT01192802
Locations
🇬🇦

Medical research Unit of Lambaréné, Lambarene, Moyen ogooue, Gabon

Activity of Mefloquine Against Urinary Schistosomiasis

Phase 2
Completed
Conditions
Urinary Schistosomiasis
Interventions
First Posted Date
2010-05-28
Last Posted Date
2013-01-24
Lead Sponsor
Albert Schweitzer Hospital
Target Recruit Count
65
Registration Number
NCT01132248
Locations
🇬🇦

Albert Schweitzer Hospital, Lambarene, Gabon

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath